Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Review of Neurotherapeutics|October 9, 2009
Glatiramer acetate for multiple sclerosis: a comprehensive review of mechanisms and clinical efficacyMarina Zvartau-Hind, Christina Caon, Rana Zabad, et al.CNS Drugs|July 5, 2002
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosisOmar Khan, Rana Zabad, Christina Caon, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Modeling Alzheimer's disease progression using the disease system analysis approachRoberto Gomeni, Monica Simeoni, Marina Zvartau-Hind, et al.Neurology|April 18, 2018
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravisKaren Hewett, Donald B Sanders, Richard A Grove, et al.Dementia and Geriatric Cognitive Disorders|August 25, 2010
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyMichael Gold, Claire Alderton, Marina Zvartau-Hind, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's diseaseGareth Maher-Edwards, Carolyn Watson, John Ascher, et al.Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.Pageof 1